Sunday, April 26, 2009: 8:00 AM-9:30 AM
Session Organizer:
Emma Webb, ACCP
Evaluation of agreement between the drug interaction probability score (DIPS) and Naranjo scale (NS) for drug interaction-induced ADRs in warfarin patients
Katherine M. Malloy, Pharm.D., UKHealthCare;
Daniel A. Lewis, Pharm.D., BCPS, UKHealthCare;
Kelly M. Smith, Pharm.D., BCPS, FASHP, FCCP, UKHealthCare;
Douglas T. Steinke, PhD., UKHealthCare;
George A. Davis, PharmD, BCPS, UKHealthCare
The impact of enoxaparin on INR in patients monitored by point-of-care device
Larissa N. Hall, Pharm.D., MUSC Medical Center/South Carolina College of Pharmacy;
Amy N. Thompson, Pharm.D., BCPS, MUSC Medical Center/South Carolina College of Pharmacy;
Kelly R. Ragucci, Pharm.D., FCCP, BCPS, CDE, MUSC Medical Center/South Carolina College of Pharmacy
Evaluation of the incidence and risk factors of fenofibrate-associated nephrotoxicity
Rebecca L. Owens, PharmD, BCPS, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio;
Michael A. McKnight, BS, University of Texas Health Science Center San Antonio;
Christopher R. Frei, PharmD, MSc, BCPS, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio;
Laurajo Ryan, PharmD, MSc, BCPS, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio;
John R. Downs, MD, University of Texas Health Science Center San Antonio;
William D. Linn, PharmD, University of the Incarnate Word
Impact of community pharmacy-based management of a targeted diabetic population
Mindy L. Jock, Pharm.D., ProMed Family Practice;
Teresa B. Klepser, Pharm.D., Ferris State University;
Jennifer Hagerman, Pharm.D., Ferris State University;
Michael Bouthillier, BSPharm, Pharm.D., Ferris State University;
Donald G. Klepser, Ph.D., M.B.A., University of Nebraska Medical Center
Implementation and Evaluation of a Blood Pressure Monitoring Service in Grocery Store Chain Pharmacies
Mindy B. Guerra, Pharm.D., University of Iowa/Hy-vee Pharmacy;
Thane A. Kading, RPh, Hy-Vee;
Karen Farris, PhD., Professor, University of Iowa;
Jay D. Currie, PharmD, College of Pharmacy, The University of Iowa
The biopharmaceutical industry: a survey of students' perceived knowledge and interest
Benjamin P. Exter, Pharm.D., Massachusetts College of Pharmacy and Health Sciences;
James Scanlon, Pharm.D., Massachusetts College of Pharmacy and Health Sciences;
Raymond Kim, Pharm.D., Massachusetts College of Pharmacy and Health Sciences;
Hamdan Almas, Pharm.D., Massachusetts College of Pharmacy and Health Sciences;
Michael Steinberg, Pharm.D., Massachusetts College of Pharmacy and Health Sciences;
Courtney Jarvis, Pharm.D., Massachusetts College of Pharmacy and Health Sciences
Meeting expectations for National Patient Safety Goal Requirement 3E: A health literacy focused patient education program
Kristin Tuiskula, Pharm.D., St. Vincent Hospital;
Shannielle Danner, Pharm.D., Candidate, Massachusetts College of Pharmacy and Health Sciences;
Kelly Bennett, Pharm.D., Candidate, Massachusetts College of Pharmacy and Health Sciences;
Monina Lahoz, PhD, Massachusetts College of Pharmacy and Health Sciences;
Andrea Gorman, MS, RD, LDN, St. Vincent Hospital;
George Abraham, MD, MPH, St. Vincent Hospital;
Karyn Sullivan, RPh, MPH, Massachusetts College of Pharmacy and Health Sciences
Triple renin-angiotensin-aldosterone-system (RAAS) inhibition: safety and efficacy of angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB), and direct renin inhibition combination therapy
Andrea N. Traina, Pharm.D., Albany College of Pharmacy;
Michael P. Kane, Pharm.D., Albany College of Pharmacy;
Robert S. Busch, M.D., The Endocrine Group, LLP;
Gary Bakst, M.D., The Endocrine Group;
Jill M Abelseth, M.D., The Endocrine Group;
Robert A. Hamilton, Pharm.D., Albany College of Pharmacy and Health Sciences
Retrospective analysis of continuous subcutaneous insulin infusion therapy in type 2 diabetic patients and a survey assessing patient satisfaction with insulin pump therapy
Chad K. Gentry, PharmD, University of Tennessee / Holston Medical Group;
L. Brian Cross, PharmD, University of Tennessee / Holston Medical Group;
Benjamin N. Gross, PharmD, University of Tennessee / Holston Medical Group;
Joni C. Foard, PharmD, University of Tennessee / Holston Medical Group;
Sherif Yacoub-Wasef, MD, Holston Medical Group;
Emily Ham, RN, Holston Medical Group;
Kim Nuss, PA-C, Holston Medical Group
Electronic and personal health record adoption in pharmacy practice in Nebraska
Kevin T. Fuji, Pharm.D., Creighton Health Services Research Program, Creighton University School of Pharmacy and Health Professions;
Kimberly A. Galt, Pharm.D., Creighton Health Services Research Program, Creighton University School of Pharmacy and Health Professions;
Alexandra B. Serocca, B.A., Creighton University School of Pharmacy and Health Professions
Impact of an electronic risk factor assessment and medication order set on contrast induced nephropathy
Megan A. McKee, PharmD, University Health System;
Pamela R. Maxwell, Pharm.D., University Health System;
Kay Green, RPh, University Health System;
Darrel W. Hughes, Pharm.D., University Health System;
Colleen Barthol, PharmD, University Health System
Hospital Costs Associated with a Pharmacodynamic Based Clinical Pathway for Empiric Antibiotic Choice in Patients Infected with Ventilator Associated Pneumonia
Anthony M. Nicasio, Pharm.D., Center for Anti-Infective Research and Development, Hartford Hospital;
Kathryn J. Eagye, MPH, Center for Anti-Infective Research and Development, Hartford Hospital;
Effie L. Kuti, Pharm.D., University of Connecticut, School of Pharmacy;
David P. Nicolau, Pharm.D., FCCP, FIDSA, Center for Anti-Infective Research and Development, Hartford Hospital;
Joseph L. Kuti, Pharm.D., Center for Anti-Infective Research and Development, Hartford Hospital
Tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs
Jared L. Crandon, Pharm.D., BCPS, Center for Anti-Infective Research and Development, Hartford Hospital;
Aryun Kim, Pharm.D., Center for Anti-Infective Research and Development, Hartford Hospital;
David P. Nicolau, Pharm.D., FCCP, FIDSA, Center for Anti-Infective Research and Development, Hartford Hospital
An In Vitro Pharmacodynamic Model of a Human Simulated High Dose, Prolonged Infusion Meropenem Regimen against Klebsiella spp. producing the KPC Carbapenemase
Catharine C. Bulik, Pharm.D., Center for Anti-Infective Research and Development, Hartford Hospital;
Henry Christensen, BS, Center for Anti-Infective Research and Development, Hartford Hospital;
Peng Li, BS(Pharm), Center for Anti-Infective Research and Development, Hartford Hospital;
David P. Nicolau, Pharm.D., FCCP, FIDSA, Center for Anti-Infective Research and Development, Hartford Hospital;
Joseph L. Kuti, Pharm.D., Center for Anti-Infective Research and Development, Hartford Hospital
Evaluation of the effect of a transplant specialty pharmacy service line on renal allograft rejection
Nicole Kenyon, Pharm.D., University of Utah Hospitals and Clinics;
Crystal Truax, Pharm.D., University of Utah Hospitals and Clinics;
Sabrina Lee, Pharm.D., University of Utah Hospitals and Clinics;
Michael Kelly, R.Ph., University of Utah Hospitals and Clinics;
Lonnie Smith, Pharm.D., University of Utah Hospitals and Clinics
Valproate use in women of childbearing potential
Christine D. Lee, PharmD, Departments of Family Medicine and Pharmacy Practice, Idaho State University;
Rex Force, PharmD, Departments of Family Medicine and Pharmacy Practice, Idaho State University;
Brooke Pugmire, Pharm.D., Departments of Family Medicine and Pharmacy Practice, Idaho State University
![[ Visit Client Website ]](images/banner.gif)